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CRITICALLY ILL MECHANICALLYventilated patients receive in-travenous sedative and anal-gesic medications to reduce
anxiety and promote comfort and ven-
tilator synchrony. These potent medi-
cations are often administered at high
doses for prolonged periods and are as-
sociated with adverse effects such as
bradycardia, hypotension, gut dysmo-
tility, immobility, weakness, and de-
lirium.1-3 Despite protocols and seda-
tion assessment tools that guide
clinicians, patients still experience sig-
nificant levels of anxiety.4,5
Unrelieved anxiety and fear are not
only unpleasant symptoms that clini-
cians want to palliate, but increased sym-
pathetic nervous system activity can
cause dyspnea and increased myocar-
dial oxygen demand.6 Sustained anxi-
ety and sympathetic nervous system ac-
tivation can decrease the ability to
concentrate, rest, or relax.6,7 Mechani-
cally ventilated patients have little con-
trol over pharmacological interven-
tions to relieve anxiety; dosing and
frequency of sedative and analgesic medi-
cations are controlled by intensive care
unit (ICU) clinicians. Interventions are
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Importance Alternatives to sedative medications, such as music, may alleviate the
anxiety associated with ventilatory support.
Objective To test whether listening to self-initiated patient-directed music (PDM) can
reduce anxiety and sedative exposure during ventilatory support in critically ill patients.
Design, Setting, and Patients Randomized clinical trial that enrolled 373 pa-
tients from 12 intensive care units (ICUs) at 5 hospitals in the Minneapolis-St Paul,
Minnesota, area receiving acute mechanical ventilatory support for respiratory failure
between September 2006 and March 2011. Of the patients included in the study, 86%
were white, 52% were female, and the mean (SD) age was 59 (14) years. The pa-
tients had a mean (SD) Acute Physiology, Age and Chronic Health Evaluation III score
of 63 (21.6) and a mean (SD) of 5.7 (6.4) study days.
Interventions Self-initiated PDM (n=126) with preferred selections tailored by a
music therapist whenever desired while receiving ventilatory support, self-initiated use
of noise-canceling headphones (NCH; n=122), or usual care (n=125).
Main Outcomes and Measures Daily assessments of anxiety (on 100-mm visual
analog scale) and 2 aggregate measures of sedative exposure (intensity and frequency).
Results Patients in the PDM group listened to music for a mean (SD) of 79.8 (126) (me-
dian [range], 12 [0-796]) minutes/day. Patients in the NCH group wore the noise-abating
headphones for a mean (SD) of 34.0 (89.6) (median [range], 0 [0-916]) minutes/day. The
mixed-models analysis showed that at any time point, patients in the PDM group had an
anxiety score thatwas19.5points lower (95%CI,32.2 to6.8) thanpatients in theusual
care group (P=.003). By the fifth study day, anxiety was reduced by 36.5% in PDM pa-
tients.The treatmenttime interaction showedthatPDMsignificantly reducedbothmea-
suresofsedativeexposure.Comparedwithusualcare, thePDMgrouphadreducedsedation
intensity by 0.18 (95% CI, 0.36 to 0.004) points/day (P=.05) and had reduced fre-
quency by 0.21 (95% CI, 0.37 to 0.05) points/day (P=.01). The PDM group had
reduced sedation frequencyby 0.18 (95%CI, 0.36 to 0.004)points/dayvs theNCH
group (P=.04). By the fifth study day, the PDM patients received 2 fewer sedative doses
(reduction of 38%) and had a reduction of 36% in sedation intensity.
Conclusions and Relevance Among ICU patients receiving acute ventilatory sup-
port for respiratory failure, PDM resulted in greater reduction in anxiety compared with
usual care, but not compared with NCH. Concurrently, PDM resulted in greater re-
duction in sedation frequency compared with usual care or NCH, and greater reduc-
tion in sedation intensity compared with usual care, but not compared with NCH.
Trial Registration clinicaltrials.gov Identifier: NCT00440700
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needed that reduce anxiety, actively in-
volve patients, and minimize the use of
sedative medications.
Nonpharmacological interventions
such as relaxing music are effective in re-
ducing anxiety while reducing medica-
tion administration.8,9 Music is a pow-
erful distractor that can alter perceived
levels of anxiety10 by occupying atten-
tion channels in the brain with mean-
ingful, auditory stimuli11 rather than
stressful environmental stimuli. Listen-
ing to preferred, relaxing music has re-
duced anxiety in mechanically venti-
lated patients in limited trials.12-15 It is not
known if music can reduce anxiety
throughout the course of ventilatory sup-
port, or reduce exposure to sedative
medications. We evaluated if a patient-
directedmusic (PDM) interventioncould
reduce anxiety and sedative exposure in
ICU patients receiving mechanical ven-
tilation.
METHODS
A 3-group, randomized clinical trial de-
sign was used. A computer-generated
random numbers list allocated pa-
tients to 1 of 3 groups: (1) PDM inter-
vention, (2) active control with noise-
canceling headphones (NCH), or (3)
usual care in the ICU. Group assign-
ment was concealed in an opaque en-
velope. Patients were enrolled from 12
ICUs at 5 hospitals in the Minneapo-
lis-St Paul, Minnesota, area between
September 2006 and March 2011.
Patients were invited to participate
in the study if they were receiving ven-
tilatory support for acute respiratory
failure, were alert, participating in their
daily care routines, appropriately fol-
lowing commands, cognitively intact to
participate in the consent process,
and had adequate or corrected vision
and hearing. Patients were not ap-
proached if they were receiving aggres-
sive ventilatory support, requiring va-
sopressors, unresponsive or delirious,
receiving chronic ventilator support
prior to hospitalization, or had a docu-
mented mental incompetence (eg, Alz-
heimer disease).
The target sample size of 286 was
based on power analysis calculations
that required 48 hours or longer of pro-
tocol data and allowed for 20% attri-
tion. Other parameters were an  level
of .05 and a power level of 80% based
on a repeated-measures analysis of co-
variance, which provides a good ap-
proximation for mixed models. A prior
study16 had a mean (SD) score of 50.5
(29.2) mm on the visual analog scale
for anxiety (VAS-A; scale range: 0-100
mm). A difference of 15.2 mm or greater
would be detected as a statistically sig-
nificant difference among groups. For
the sedative-exposure aim, previous
data gave a mean (SD) estimate of 6.5
(4.3).17 Using the sample size deter-
mined for the VAS-A, any difference of
1.8 or greater in the sedation intensity
would be detected as a statistically sig-
nificant difference among groups.
Study approval was obtained from
the University of Minnesota’s institu-
tional review board (IRB) and from the
participating hospitals’ IRBs. Given the
patient-directed nature of the proto-
col, the IRB required patients to pro-
vide their own written informed con-
sent. To validate patient understanding
of the study’s risks, benefits, and pro-
cedures, the patient had to answer 7 yes
or no questions correctly to the re-
search nurses. If any of the questions
was answered incorrectly, that patient
was not enrolled that day but re-
mained eligible to be reapproached if
mental status improved and inclusion
criteria were still met. Trained re-
search nurses obtained all written con-
sents.
Data were obtained on sex, age, days
mechanically ventilated, and days in the
ICU prior to enrollment, diagnoses,
ventilator settings, and all medica-
tions received 24 hours prior to enroll-
ment. Data from each patient’s ICU ad-
mission day were abstracted from the
medical record to calculate the Acute
Physiology, Age and Chronic Health
Evaluation III (APACHE III) score,
which was used as a covariate to con-
trol for illness severity.
Anxiety was defined as a state marked
by apprehension, agitation, increased
motor activity, arousal, and fearful with-
drawal.18 Anxiety was assessed via self-
report at study entry and daily while
ventilated using the 100-mm VAS-A,
which was presented to patients with
a vertical orientation like a thermom-
eter. The bottom of the scale was an-
chored by the statement “not anxious
at all” and the top was anchored by
“most anxious ever.” Patients indi-
cated their current level of anxiety in
response to “How are you feeling to-
day?” The VAS-A score was the num-
ber of millimeters from the bottom edge
of the line anchor to the patient’s mark.
The VAS-A and the Spielberger State
Anxiety Inventory are correlated
(r=0.4916 to r=0.8219), demonstrating
concurrent validity.
Sedative exposure was determined
for all patients who received any of 8
commonly administered sedative and
analgesic medications in the ICU (mid-
azolam, lorazepam, propofol, dexme-
detomidine, morphine, fentanyl, hy-
dromorphone, haloperidol) 24 hours
prior to enrollment and each day dur-
ing the study. Sedative exposure was
operationalized as a daily sedative drug
intensity score and sedative dose fre-
quency.17 The usual practice at the par-
ticipating ICUs consisted of physi-
cians writing orders for sedation therapy
per their individual preferences with the
nurses managing administration of
these medications within the para-
meters of the orders. Sedative admin-
istration was not directed by a specific
unit protocol or by a study protocol.
The sedative drug intensity score ag-
gregated dose amounts of medica-
tions from disparate drug classes by
using a weight-adjusted dose (adjust-
ing for differing patient weights) of each
sedative administered during 4-hour
time blocks during mechanical venti-
lation. Every drug amount (eg, 2 mg of
lorazepam administered between noon
and 4 PM) was then placed into quar-
tiles created by using all patients’ lor-
azepam data during the entire time they
received the study protocol; 2 mg of lor-
azepam might fall into quartile 2. If fen-
tanyl also was given at a dose that fell
into quartile 3 for all fentanyl doses
within the entire sample, then the
noon-4 PM value was 5 (23). If none
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of the 8 medications was given, the
value was 0. The values were summed
over the six 4-hour blocks to produce
a daily sedative drug intensity score. For
dose frequency, a 24-hour day was di-
vided into six 4-hour time blocks and,
for each of the 8 drugs, the occur-
rences in which a sedative was admin-
istered at least once during that inter-
val were summed. This approach to
sedative exposure accounts for medi-
cations administered to patients from
nonequivalent, disparate drug classes.17
The environmental scan form was de-
veloped for this study to collect data on
the overall activity level in the pa-
tient’s room each shift and on ICU nurs-
ing experience. Nurses were invited to
provide any comments about the study
protocol. This paper and pencil form
was adhered to a brightly colored clip-
board kept at each participant’s bed side.
A starter set of 6 CDs were reviewed
with the patient by the research nurse
to provide for immediate listening upon
randomization to the PDM group. The
starter set included relaxing music
played on piano, harp, guitar, and Na-
tive American flute. The research nurse
oriented the patient to CD player and
headphone operation. A standard CD/
MP3 player with comfortable, noise-
abating headphones was kept within
easy reach to allow the patient to self-
initiate music listening.
Within24hoursofrandomization,the
music therapist completed a music pref-
erence assessment on each PDM patient
usingatooldesignedtoassessmusicpref-
erences of mechanically ventilated pa-
tients with a simple yes or no format.20
Patientswerepromptedverballyandwith
posted signs to use music at least twice
per day when feeling anxious and/or to
providerelaxation,butwereencouraged
to self-initiate music listening as fre-
quentlyasdesired.Nursingstaffwereen-
couragedtooffermusicat least twicedur-
ing their shift, but were reminded by the
research staff that the decision to listen
was determined by the patient. A data-
logger system on the headphones cap-
tured each PDM session and total daily
music listening time; system details are
described elsewhere.21
Patients randomized to the active
control NCH group were encouraged
to wear headphones whenever they
wanted to block out ICU noise or have
some quiet time. As with the PDM
group, NCH patients self-initiated head-
phone use. Patients randomized to the
usual care control group received stan-
dard ICU care for that respective unit.
Patients had daily assessment visits by
a research nurse who administered the
VAS-A. Patients remained on protocol
up to 30 days as long as they were re-
ceiving ventilatory support.
Descriptive statistics and graphing
were performed on all study data to as-
sess the distributions of the variables.
We used bivariate associations to iden-
tify covariates to be considered in sub-
sequent analyses. Covariates were not
included to assess their effect per se or
to adjust for imbalance among groups,
but were included if significantly asso-
ciated with the outcome to subtract the
variability piece they represent and thus
gain efficiency.
Patients with at least 2 days of VAS-A
scores and sedative exposure data were
used in the change over time analyses.
Change over time was assessed as the
slope of the outcome variables deter-
mined from one day to the next using
the best fitting line. We used mixed-
effects models to analyze anxiety and
sedative exposure (sedation intensity
scores and sedation frequency) be-
cause they accommodate measures that
are correlated from one time point to
another and have variances that are not
constant from one time point to an-
other, which would be expected in a
repeated-measures analysis of covari-
ance. This is the recommended mod-
eling for intent-to-treat analyses.22 Using
the data as is within a mixed-model
analysis has a lower type I error and
higher power than any type of impu-
tation method used for missing data,
which would be needed for a repeated-
measures analysis of covariance. Also,
imputation may result in biased esti-
mates of effects and standard errors. A
series of models were estimated and
compared with the Aikake informa-
tion criterion and the Bayesian infor-
mation criterion to determine the best
model of change for the anxiety and
sedative exposure data.
An unconditional means model was
used to assess 2 null hypotheses: no
change across occasions; and no varia-
tion among patients. Rejecting these null
hypotheses warrants further analysis. An
unconditional growth model with day
added as a predictor incorporated esti-
mation of change coefficients. Models
with several within-person error cova-
riance structures that were compatible
with the correlation pattern between
anxiety measures and sedative expo-
sure measures at different time points
were explored. The best fit was the au-
toregressive plus random-effects cova-
riance structure that assumes correla-
tions decrease as the lag time increases
and that covariance also comes from
measures within subject. An uncondi-
tional growth model with a quadratic
term was also explored to assess if there
were nonlinear changes in sedative ex-
posure measures over time.
A conditional growth model intro-
duced the effect of the intervention and
included any covariates found to be as-
sociated with the outcome. These were
included in the analysis to eliminate the
variability attached to them and im-
prove the precision of the  estimates.
Post hoc multiple comparisons were
completed within the mixed model-
ing controlling the overall  level at .05.
We used SPSS version 17 (SPSS Inc) and
SAS version 9.2 (SAS Institute Inc) sta-
tistical software. Final parameter esti-
mates were considered significant at a
P value of .05 or less with a 2-sided .
RESULTS
TABLE 1 summarizes the characteris-
tics of the patients. The mean age was
59 years with a wide range of APACHE
III scores. The primary indication for
mechanical ventilation was respira-
tory failure or distress. Only median
ICU days prior to enrollment were sig-
nificantly different at study entry; NCH
patients were in the ICU 1 to 2 days lon-
ger prior to enrollment than PDM or
usual care patients. Patients remained
on protocol for a mean (SD) of 5.7 (6.4)
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days (median, 3.2 [range 1-30] days).
FIGURE 1 details patient flow through
the study.
The PDM patients listened to music
for a mean (SD) of 79.8 (126) minutes/
day (median, 12 [range, 0-796] min-
utes/day). The NCH patients wore the
noise-abating units for a mean (SD) of
34.0 (89.6) minutes/day (median, 0
[range, 0-916] minutes/day). There was
no linear relationship between device
use time and anxiety for either the PDM
group (r=0.07; P= .14) or the NCH
group (r=0.06; P=.23). More PDM
patients were extubated at the end of
the study (Table 1).
The analysis is from the 241 pa-
tients with 2 or more anxiety assess-
ments in order to model change. Not
all patients were able to provide anxi-
ety assessments each day due to fa-
tigue, medical condition, state of seda-
tion, inability or refusal to complete
assessments, or were off the unit
(Figure 1). Unadjusted mean VAS-A
score was not significantly different
among groups at study entry (Table 1).
We did not observe a nonlinear pat-
tern or any obvious inflection point in
the individual patterns of change; there-
fore, change was modeled as linear.
Both the unconditional means model
and the unconditional growth model in-
dicated significant unexplained vari-
ance that warranted further modeling.
Covariates of interest in the model were
scores on the APACHE III and VAS-A
at enrollment and sedative exposure.
Two final models were produced
using either sedation frequency or se-
dation intensity (TABLE 2). After the ad-
justment due to APACHE III and se-
dation frequency and intensity, the
adjusted baseline VAS-A score was dif-
ferent among study groups, and the in-
teraction of baseline with treatment
group was significant. Pairwise com-
parisons indicated that PDM patients
had a significantly lower VAS-A score
at study entry than usual care pa-
tients, regardless of whether sedation
intensity or frequency was used. Seda-
tion intensity (=0.75 [95% CI, 0.01
to 1.50]; P=.05) was associated with
higher VAS-A scores. After adjusting for
these covariates, the final models
showed that the main effect of PDM was
to lower VAS-A scores consistently by
more than 19 mm during the study pe-
riod compared with usual care (seda-
tion intensity: =19.3 [95% CI, 32
to 6.6]; and sedation frequency:
=19.5 [95% CI, 32.2 to 6.8];
P=.003 for both) (FIGURE 2).
The analysis is from the 266 pa-
tients who were on protocol for 48
hours or longer. A linear pattern of
change was supported by graphs of se-
dation intensity and frequency over
time. Sedation frequency and inten-
sity were not significantly different












Age, mean (SD), y 60.4 (15.4) 59.4 (14.3) 57.8 (13.5) .37
Female sex, No. (%) 68 (54) 56 (46) 69 (55) .28
APACHE III score, mean (SD) 63.1 (18.7) 62.2 (22.3) 65.6 (23.5) .43
Length of ICU stay prior to study entry, median
(range), d
6 (0-40) 8 (1-85) 7 (0-33) .02
Ventilator use, median (range), d
Prior to study entry 4.5 (0-35) 6.0 (1-79) 6.0 (0-38) .11
Prior to study entry  study days 7.5 (1-53) 7.3 (1-47) 7.7 (1-46) .74
Enrolled per protocol, median (range), d 3.0 (1-27) 3.6 (1-30) 3.8 (1-30) .66
VAS-A score at study entry, mean (SD), mm 51.9 (32.4) 49.0 (30.1) 52.3 (29.7) .66
Sedation 24 h prior to enrollment, median (range)
Intensity score 4.0 (0-12) 3.5 (0-10) 4.0 (0-12) .07
Frequency 7.0 (0-18) 6.0 (0-19) 6.0 (0-14) .14
Extubated at end of study, No. (%) 89 (71) 67 (55) 83 (66) .02
Alive at end of study, No. (%) 115 (91) 111 (91) 109 (87) .65
Primary ICU admission diagnosis category, No. (%)
Pulmonary 77 (61) 70 (57) 71 (57)
Cardiac
Medical 14 (11) 9 (7) 9 (7)
Surgical 0 3 (2) 3 (2)
Sepsis or infection 10 (8) 7 (6) 6 (5)
Gastrointestinal 6 (5) 8 (7) 7 (6)
Neurological or neuromuscular 2 (2) 6 (5) 7 (6)
Oncology 4 (3) 3 (2) 4 (3)
Shock or hypotension 3 (2) 2 (2) 5 (4)
Trauma 3 (2) 4 (3) 2 (2)
Surgical 2 (2) 3 (2) 0
Vascular 2 (2) 0 2 (2)
Other or missing 3 (2) 7 (6) 9 (7)
Indication for mechanical ventilation, No. (%)
Respiratory failure 63 (50) 63 (52) 61 (49)
Respiratory distress 32 (25) 27 (22) 36 (29)
Pneumonia 7 (6) 5 (4) 7 (6)
Respiratory arrest 3 (2) 4 (3) 4 (3)
Airway protection 2 (1) 5 (4) 4 (3)
Surgery or postoperative 2 (1) 3 (2) 4 (3)
COPD 7 (6) 4 (3) 0
Hypoxia 2 (1) 3 (2) 2 (2)
ARDS 1 (1) 1 (1) 0
Tachypnea 1 (1) 0 1 (1)
Cardiac arrest 4 (3) 2 (2) 5 (4)
Pulmonary edema 1 (1) 0 0
Asthma 0 0 1 (1)
Other or missing 1 (1) 5 (4) 0
Abbreviations: APACHE III, Acute Physiology, Age and Chronic Health Evaluation III; ARDS, acute respiratory distress syn-
drome; COPD, chronic obstructive pulmonary disease; ICU, intensive care unit; VAS-A, visual analog scale for anxiety.
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among groups 24 hours prior to study
entry (Table 1).
Covariates associated with sedation
intensity and sedation frequency were
age, sex, and APACHE III scores. Age
was significant in both models; the
higher the age, the lower the sedation
intensity or sedation frequency. In the
models, there was a significant inter-
action between the PDM group and
time, which showed a decrease in se-
dation intensity and sedation fre-
quency over time (per day) for the PDM
group only (Table 2). In post hoc pair-
wise comparisons, the PDM group had
a greater decrease in the change over
time of the sedation intensity score
compared with the usual care group
(=0.18 [95% CI, 0.36 to 0.004];
P=.05). Using the sedation frequency
measure, the PDM group had a greater
decrease in the change over time com-
pared with the usual care group
(=0.21 [95% CI, 0.37 to 0.05];
P=.01) and the NCH group (=0.18
[95% CI, 0.36 to 0.004]; P=.04)
(FIGURE 3 and FIGURE 4).
For an average patient on the fifth
study day (the average time patients
were enrolled), a usual care patient re-
ceived 5 doses of any 1 of the 8 study-
defined sedative medications. An
equivalent PDM patient received just 3
doses on the fifth day, a relative reduc-
tion of 38%. By the end of the fifth day,
an average usual care patient had a se-
dation intensity score of 4.4. An equiva-
lent PDM patient had a sedation inten-
sity score of 2.8, a relative reduction of
36%. By the end of the fifth day, an av-
erage usual care patient had an anxi-
ety score of 52. An equivalent PDM pa-
tient had an anxiety score of 33, which
is an absolute difference of 19 on a 100-
point scale and a relative reduction of
36.5% (TABLE 3).
Nurses caring for patients had a me-
dian of 5.9 years (range, 0.25-44 years)
of ICU experience. When asked to ap-
praise the shift activity in the patient’s
room, 21% of the nurses said quiet, 49%
said it was at a usual pace, 24% said it
was busy, 6% said it was very busy to
hectic. Comments included the nurses’
efforts offering PDM or headphones to
patients and their observations of the
protocol (BOX).
Figure 1. Flow Diagram of Study
7074 Patients assessed for eligibility a
82 Included in anxiety analysis b
44 Excluded from anxiety analysis
(<2 anxiety measurements c)
87 Included in sedation analysis b
35 Excluded from sedation analysis
(<48 h in study)
83 Included in anxiety analysis b
42 Excluded from anxiety analysis
(<2 anxiety measurements c)
89 Included in sedation analysis b
35 Excluded from sedation analysis
(<48 h in study)
76 Included in anxiety analysis b
46 Excluded from anxiety analysis
(<2 anxiety measurements c)
90 Included in sedation analysis b
28 Excluded from sedation analysis
(<48 h in study)




4 Did not receive patient-directed
music as randomized
3 Ineligible on chart review
1 Unable to wear equipment
125 Randomized to receive usual care
124 Received usual care as randomized
1 Did not receive usual care as
randomized (ineligible on chart review)
122 Randomized to receive noise-canceling
headphones only
118 Received noise-canceling
headphones only as randomized
4 Did not receive noise-canceling
headphones only as randomized
2 Ineligible on chart review
2 Withdrew due to group assignment
0 Lost to follow-up
8 Discontinued intervention
2 Disliked equipment
2 No reason given
1 Family request
1 Too tired
2 Removed after protocol initiation
1 Worsening physiological status
1 Protocol deviation
0 Lost to follow-up
4 Discontinued intervention
1 No reason given
3 Removed after protocol initiation
2 Worsening physiological status
1 Protocol deviation
0 Lost to follow-up
8 Discontinued intervention
1 Disliked equipment
3 No reason given
1 Family request
3 Removed after protocol initiation
1 Worsening physiological status
2 Unable to complete assessments
6701 Excluded
5627 Did not meet inclusion criteria
748 Refused to participate







aThis number is an estimate based on the number of days patients were mechanically ventilated, screened, and had confirmed pulmonary diagnosis.
bThose who withdrew or were removed after completing at least 48 hours in the study were included in the analysis.
cThe reasons why anxiety assessment was not completed included sedated, sleeping, off unit, too tired, and unable to respond to questions.
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DISCUSSION
The 2 primary study aims were to de-
termine if PDM reduced anxiety and
sedative exposure in a sample of pa-
tients receiving mechanical ventila-
tory support. The PDM intervention de-
creased anxiety and sedative exposure
over time more effectively than usual
care or NCH. To our knowledge, these
findings are from the first randomized
clinical trial to test an integrative
therapy for self-management of anxi-
ety in ventilated ICU patients that does
not rely solely on medications. The
unique approach involving patients
themselves in self-management of anxi-
ety launches a novel area of ICU clini-
cal research.
The PDM protocol was modeled af-
ter the patient-controlled analgesia in-
tervention whereby patients report bet-
ter pain control and are more satisfied
when they self-administer analgesic
therapy.8,23,24 Music provides patients
with a comforting and familiar stimu-
lus and the PDM intervention empow-
ers patients in their own anxiety man-
agement; it is an inexpensive, easily
implemented nonpharmacological in-
tervention that can reduce anxiety, re-
duce sedative medication exposure, and
potentially associated adverse ef-
fects.25-29 The PDM patients received less
Table 2. Final Models for Anxiety and Sedative Exposure Based on 2 or More Days of Dataa
Model Results for VAS-A (n = 241) Model Results for Sedation (n = 266)
Sedation Frequency Sedation Intensity Intensity Frequency
 (95% CI)b
P
Value  (95% CI)b
P
Value  (95% CI)c
P

























































































































Abbreviations: APACHE III, Acute Physiology, Age and Chronic Health Evaluation III; VAS-A, visual analog scale for anxiety.
aThe following sentence is an example of how to interpret this table. The formula to predict sedation frequency for the patient-directed music group at any time point: sedation
frequency=7.3 minus 0.17 (day in study) minus 0.21 (day if in the patient-directed music group) plus 0.69 (if in the patient-directed music group) plus 0.005 (APACHE III score)
minus 0.04 (age) plus 0.94 (if female).
b Indicates change in millimeters for VAS-A for 1 unit change in predictor.
c Indicates change in sedation intensity for 1 unit change in predictor.
d Indicates change in sedation frequency for 1 unit change in predictor.
eRepresents the overall average of frequency sedation at baseline (7.3 doses). Each patient’s dose decreased by an average of 0.17 doses per day. If the patient was in the
patient-directed music group, for each day, the dose frequency decreases by another 0.21 points per day (0.170.21=0.38). If the patient was in the patient-directed music
group, the baseline average was 0.69 higher (7.300.69=7.99), every increase of 1 point in the APACHE III score raises the total daily dose frequency by another 0.005. For
every 1 year older a patient was, his/her sedation frequency decreased by 0.04 points. If the patient was female, the dose frequency increased by 0.94.
fThe data in columns 2 through 5 are for VAS-A scores at day 0.
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The diagonal and horizontal lines are the best fitted lines to demonstrate change over the study period.






































































The diagonal and horizontal lines are the best fitted lines to demonstrate change over the study period.
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frequent and less intense sedative regi-
mens while reporting decreased anxi-
ety levels.
We report a reduction in sedative ex-
posure with PDM using a method to ag-
gregate medications from disparate drug
classes. This is a significant finding in that
strategies are needed to reduce the
amount and frequency sedative medica-
tions are administered to mechanically
ventilatedICUpatients.Anappropriately
tailored music intervention holds great
promise for use in clinical practice as a
methodtopotentiallyavoidorreducethe
cumulativeadverseeffectsof thesepotent
medications, but requires further study.
As more clinicians are advocating to
minimize sedative administration,30,31






































































The diagonal lines are the best fitted lines to demonstrate change over the study period.








Estimated VAS-A Score, mm
Intensity Frequency

















Median score 64 4 7 52 33 44 52 32 43 51
Estimated Sedation Measures
Intensityd Frequencye
Median score 64 4 7 Female
sex
2.8 4.2 4.4 3.3 5.2 5.3
Abbreviation: APACHE III, Acute Physiology, Age and Chronic Health Evaluation III.
aSedative exposure defined as the dose frequency and the sedation intensity. Patient age of 60 years, APACHE III scores, and study day 5 kept constant throughout model.
b It would be estimated that the usual care group would have an anxiety rating of 52 mm at 5 days into the study. For the noise-canceling headphones group, they would have an
anxiety rating of 44 mm, a decrease of 8 points (in millimeters). For the patient-directed music group, they would have an anxiety rating of 33 mm, a decrease of 19 mm from usual
care at 5 days into the study. By day 5, patient-directed music reduces VAS-A score by 37% compared with usual care.
cThe usual care group would have an anxiety rating of 51 mm at 5 days into the study. The noise-canceling headphones group would have an anxiety rating of 43 mm, a decrease
of 8 points (in millimeters). The patient-directed music group would have an anxiety rating of 32 mm, a decrease of 19 mm from usual care. By day 5, patient-directed music
reduces VAS-A score by 37% compared with usual care.
d Indicates the sum of the dose quartiles over 8 medications. For an average patient with usual care, his/her sedation intensity score would be 4.4 at 5 days into the study. The
noise-canceling headphones group would be 4.2, a decrease of 0.2. The patient-directed music group would be 2.8, a decrease of 1.6 from usual care. By day 5, patient-
directed music reduces sedation intensity by 36% compared with usual care.
eFor an average patient in usual care, his/her sedation frequency score would be 5.3 at 5 days into the study. The noise-canceling headphones group would be 5.2, a decrease of
0.1. The patient-directed music group would be 3.3, a decrease of 2.0 from usual care at 5 days. By day 5, patient-directed music reduces sedation frequency by 38% compared
with usual care.
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our data suggest that patients still ex-
perience moderate levels of anxiety. Pa-
tients in this study with higher seda-
tion intensity scores had higher VAS-A
scores. This finding is consistent with
previous investigations that demon-
strate ICU patients report moderate
anxiety levels throughout the course of
ventilatory support, despite receiving
sedative medications.7 Given the det-
rimental physiological and psychologi-
cal effects of sustained anxiety, it is im-
portant that this symptom be effectively
managed. As clinicians seek lighter
sedative regimens in the ICU, PDM may
be an appropriate adjunctive interven-
tion by which patients can self-
manage anxiety. There were no com-
ments from nurses that would suggest
the study protocol was burdensome to
their patient care practices.
Because patients were enrolled
when they were not receiving high
levels of sedative medications (other-
wise they would have been too
sedated to provide consent at enroll-
ment), it is difficult to interpret the
pharmacological or cost significance
of a reduction in sedative exposure in
the days after enrollment compared
with the higher doses patients likely
received earlier in their episode of
respiratory failure. However, even
with a modest reduction in sedative
exposure, patients assigned to PDM
also experienced less anxiety com-
pared with usual care.
There are a number of limitations to
this study. Because research nurses
completed the anxiety assessments (to
ensure consistent administration and
minimize influence on the bedside
nurse’s practice), only 1 anxiety assess-
ment was performed daily. For some pa-
tients, the assessment was not per-
formed in relation to use of the PDM
intervention, and if the patient was not
available or the patient deferred due to
fatigue, medical condition, or was se-
dated, the assessment was not com-
pleted (Figure 1).
Because the intervention was initi-
ated by the patient, not all those ran-
domized to PDM actually used music
twice daily. Some patients may have re-
lied on the bedside nurse to assist with
the equipment. This may have af-
fected the length or frequency of mu-
sic listening by patients or the nonsig-
nificant relationship between music
listening time and anxiety. However,
simply having the option and availabil-
ity of PDM may provide patients a sense
of control over one aspect of their
ICU care. Given that anxiety is an
Box. Summary of Intensive Care Unit Nurse Written Comments
and Observations
Patient-directed music group
Patient’s wife says he listens to the music all of the time and it has been working
well. Patient was sleeping with headphones on with his wife sleeping next to
him in a chair.
Patient looks very peaceful and states she likes the music.
Patient was tapping fingers to some of the music provided to him by the music
therapist.
Patient listened to music most of yesterday (about 10 h). Tends to be anxious
and her blood pressure is lower when she is listening to music.
Patient likes music and always nods head “yes” to have headphones in place
when asked.
After putting headphones on, patient appears less anxious.
Patient wears headphones very often and rests well with them in place. Always
nods “yes” to wearing headphones.
Patient has been tapping feet to the music and listens for a couple of hours each
night; seems happy with it!
After putting headphones on, patient appears less anxious.
Able to decrease propofol slightly.
Evening was quieter. Patient put headset on which seemed to help a lot.
Family visited for 1 h. Patient had difficulty sleeping; tried reading and quiet
time before using headphones.
Patient calm and resting with headphones on.
Patient was relaxing with music on for 3 h.
Patient slept well, headphones for 3 h.
Music was on entire night (8-h shift).
Noise-canceling headphones group
Patient really benefited from headphones!
Patient relaxed with headphones.
I’m glad he’s participating. I think the headphones will help him rest.
The headphones would help her get more rest (due to the commotion on the
other side of the curtain with roommate).
The patient wanted to wear the headphones most of the day yesterday and com-
municated that they helped her rest.
Patient put headphones on without prompting.
Headphones helped patient sleep during dialysis.
Patient wanted to wear headphones all night.
Patient had earphones on about 1 h early in the night, then declined to use them
the rest of night.
Headphones decrease nerves (per patient and patient’s wife).
Patient appeared calmer with headphones on.
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individually perceived symptom, self-
initiation of treatment with music
whenever desired and for as long as de-
sired is the preferred method of music
listening much in the same manner
as patient-controlled analgesia for pain
relief.
Only a small number of nurses pro-
vided written comments about the pro-
tocol. While positive, it is unknown if
the ICU nurses were reluctant to re-
cord negative comments, despite the
comments being anonymous. We did
not query nurses for the reasons why
they administered sedative medica-
tions to study patients. The ICU nurses
were not blinded to assignment group,
which may have introduced bias into
the study. Furthermore, we did not col-
lect data from patients after they were
extubated or transferred from the ICU.
CONCLUSIONS
Among ICU patients receiving acute
ventilatory support for respiratory fail-
ure, PDM resulted in greater reduc-
tion in anxiety compared with usual
care, but not compared with NCH.
Concurrently, PDM resulted in greater
reduction in sedation frequency com-
pared with usual care or NCH, and
greater reduction in sedation intensity
compared with usual care, but not com-
pared with NCH.
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